Literature DB >> 26671127

A novel embolic middle cerebral artery occlusion model induced by thrombus formed in common carotid artery in rat.

Yin-Zhong Ma1, Li Li1, Jun-Ke Song1, Zi-Ran Niu1, Hai-Feng Liu2, Xiang-Shan Zhou3, Fu-Sheng Xie4, Guan-Hua Du5.   

Abstract

Stroke is a major cause of death and disability worldwide. However, treatment options to date are very limited. To meet the need for validating the novel therapeutic approaches and understanding the physiopathology of the ischemic brain injury, experimental stroke models were critical for preclinical research. However, commonly used embolic stroke models are reluctant to mimic the clinical situation and not suitable for thrombolytic timing studies. In this paper, we established a standard method for producing a rat embolic stroke model with autologous thrombus formed within the common carotid artery (CCA) by constant galvanic stimulation. Then the thrombus was shattered and channeled into the origin of the MCA and small (lacunar) artery. To identify the success of MCA occlusion, regional cerebral blood flow was monitored, neurological deficits and infarct volumes were measured at 2, 4 and 6h postischemia. This model developed a predictable infarct volume (38.37 ± 2.88%) and gradually reduced blood flow (20% of preischemic baselines) within the middle cerebral artery (MCA) territory. The thrombus occluded in the MCA was able to be lysed by a tissue-type plasminogen activator (t-PA) within 4h postischemia. The techniques presented in this paper would help investigators to overcome technical problems for stroke research.
Copyright © 2015. Published by Elsevier B.V.

Entities:  

Keywords:  Cerebral embolism; Disease model; Stroke; Therapeutic time window; Thrombolytic; t-PA

Mesh:

Substances:

Year:  2015        PMID: 26671127     DOI: 10.1016/j.jns.2015.09.362

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  6 in total

1.  Long-term administration of salvianolic acid A promotes endogenous neurogenesis in ischemic stroke rats through activating Wnt3a/GSK3β/β-catenin signaling pathway.

Authors:  Sen Zhang; De-Wen Kong; Guo-Dong Ma; Cheng-di Liu; Yu-Jiao Yang; Shan Liu; Nan Jiang; Zi-Rong Pan; Wen Zhang; Ling-Lei Kong; Guan-Hua Du
Journal:  Acta Pharmacol Sin       Date:  2022-02-25       Impact factor: 7.169

2.  Salvianolic acid A prevented cerebrovascular endothelial injury caused by acute ischemic stroke through inhibiting the Src signaling pathway.

Authors:  Cheng-di Liu; Nan-Nan Liu; Sen Zhang; Guo-Dong Ma; Hai-Guang Yang; Ling-Lei Kong; Guan-Hua Du
Journal:  Acta Pharmacol Sin       Date:  2020-12-10       Impact factor: 6.150

3.  Pinocembrin attenuates hemorrhagic transformation after delayed t-PA treatment in thromboembolic stroke rats by regulating endogenous metabolites.

Authors:  Ling-Lei Kong; Li Gao; Ke-Xin Wang; Nan-Nan Liu; Cheng-di Liu; Guo-Dong Ma; Hai-Guang Yang; Xue-Mei Qin; Guan-Hua Du
Journal:  Acta Pharmacol Sin       Date:  2021-04-15       Impact factor: 7.169

4.  Pinocembrin Protects Blood-Brain Barrier Function and Expands the Therapeutic Time Window for Tissue-Type Plasminogen Activator Treatment in a Rat Thromboembolic Stroke Model.

Authors:  YinZhong Ma; Li Li; LingLei Kong; ZhiMei Zhu; Wen Zhang; JunKe Song; Junlei Chang; GuanHua Du
Journal:  Biomed Res Int       Date:  2018-04-22       Impact factor: 3.411

5.  Edaravone Exerts Brain Protective Function by Reducing the Expression of AQP4, APP and Aβ Proteins.

Authors:  Haiyan Ren; Lijuan Ma; Xueli Gong; Chenbo Xu; Yuge Zhang; Meilei Ma; Kenichi Watanabe; Juan Wen
Journal:  Open Life Sci       Date:  2019-12-31       Impact factor: 0.938

6.  Cytomembrane ATP-sensitive K+ channels in neurovascular unit targets of ischemic stroke in the recovery period.

Authors:  Yang Zhang; Sipei Pan; Xiaolu Zheng; Qi Wan
Journal:  Exp Ther Med       Date:  2016-05-20       Impact factor: 2.447

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.